Medal is a healthcare information technology pioneer that uses natural language processing and machine learning to harmonize healthcare information across large data sets on disparate platforms. Specifically, Medal specializes in extracting data from disparate sources including EMR/EHRs, HIEs, legacy databases, and even standalone files in fax and paper format. Medal then transforms and indexes the data into a cohesive narrative of who the patient is, making it accessible to use.
“We believe that Health Catalyst Capital will be a strong partner as we continue to develop our technology and roll it out to customers nationally,” said Lonnie Rae Kurlander, Co-Founder and CEO of Medal. “We’re excited to have a partner on board that provides us not only capital, but also extensive strategic experience in the healthcare market.”
Health Catalyst Capital invests in multiple-stages of high-growth healthcare IT and tech-enabled services companies. Investors in HCC’s fund include several major healthcare companies, such as large health plans and providers.
“We are excited to partner with the dynamic team at Medal,” said Charles Boorady, Founding Managing Director of Health Catalyst Capital. “Interoperability is an investment theme that we at HCC have focused on for a long time. We believe that Medal is a leader in that very important field, and its work will lead to significant improvement in patient care while providing major efficiencies at the same time.”
Medal will be exhibiting at the Health Information and Management Systems Society (HIMSS) conference February 10-15, 2019 in Orlando, Florida. Medal will exhibit in Booth 509 with its business partner NewWave Telecom and Technologies, Inc
About Medal, Inc.
Medal is a digital health company that uses natural language processing and machine learning to make healthcare data systems interoperable, thus providing better medical information and major market efficiencies. Founded in 2015, Medal has offices in San Francisco. For more information, see https://www.medal.com/.
About Health Catalyst Capital
Health Catalyst Capital Management, LLC (“HCC”) is an independent private equity firm that advises with respect to investments primarily in venture to growth stage healthcare information technology and technology-enabled services businesses including artificial intelligence, genomic data analytics and informatics. HCC was formed by a team of experienced healthcare investors and operators seeking profitable investment opportunities, while at the same time seeking to improve the human condition and promote value-based care. Health Catalyst Capital, L.P. invested in Medal as part of its systematic review of companies developing technologies related to Interoperability. HCC remains active in this investment theme and others.
HCC seeks investment opportunities primarily in the investment themes related to Genomics / Personalized Medicine, Patient Navigation, Referral Management, Value-based Care, Interoperability and Aging in Place. HCC’s investment process typically proceeds as follows:
- HCC identifies an investment theme, and investigates companies in or close to it
- After investigating investment opportunities within that theme, invest early with a leader
- Reserve for follow – on investment
- Pursue strategic alternatives / corporate combinations to accelerate growth
- Exit the investment in a timely and appropriate manner